Investigators sought to determine the effect dupilumab has on patch testing results and improvement of allergic contact dermatitis in patients with allergic dermatitis.
Results from two phase 3 studies evaluating an investigational antihistamine-releasing contact lens (etafilcon A with ketotifen 0.019mg) showed that the treatment may benefit patients who need vision correction and also suffer from ocular allergies.
Montelukast plus levocetirizine demonstrated a significant reduction in mean daytime nasal symptom scores compared with montelukast monotherapy.
Children of East Asian-born parents had an increased risk for allergic rhinitis and aeroallergen sensitization compared with children of Caucasian ancestry.
Although allergic sensitization and hay fever rates increased as children grew older, the rates of asthma dropped.
Prenatal vitamin D is associated with an increased risk for allergic rhinitis in children born to African American women, but not white women.
Intranasal corticosteroids are the current guideline-preferred treatment recommendation for nasal congestion.
Exposure during infancy was associated with increased risk up to 16 years of age, especially for nonallergic disease.
Allergic rhinitis is the twelfth most common diagnosis made at family physician visits.
Researchers measured rates of childhood allergic conditions with data from healthcare provider-based diagnoses.
